Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.430
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
1.400
-0.030 (-2.10%)
After-hours: Jun 27, 2025, 7:57 PM EDT
Traws Pharma Revenue
Traws Pharma had revenue of $57.00K in the quarter ending March 31, 2025, with 1.79% growth. This brings the company's revenue in the last twelve months to $227.00K, up 0.44% year-over-year. In the year 2024, Traws Pharma had annual revenue of $226.00K.
Revenue (ttm)
$227.00K
Revenue Growth
+0.44%
P/S Ratio
19.43
Revenue / Employee
$32,429
Employees
7
Market Cap
7.96M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TRAW News
- 24 days ago - Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib - GlobeNewsWire
- 4 weeks ago - Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness - GlobeNewsWire
- 6 weeks ago - Traws Pharma Reports First Quarter 2025 Results and Business Highlights - GlobeNewsWire
- 3 months ago - Traws Pharma, Inc. (TRAW) Virtual Investor Event Transcript - Seeking Alpha
- 3 months ago - Traws Pharma Announces Management Updates - GlobeNewsWire
- 3 months ago - Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET - GlobeNewsWire
- 3 months ago - Traws Pharma's COVID-19 Candidate, Ratutrelvir, Presented at ICAR - GlobeNewsWire
- 3 months ago - Traws Pharma's Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR - GlobeNewsWire